Serum ferritin and vitamin D in female hair loss: Do they play a role?

Skin Pharmacology and Physiology

Volumn 26, Issue 2, 2013, Pages 101-107

  Rasheed, H ^a   Mahgoub, D ^a   Hegazy, R ^a   El Komy, M ^a   Abdel Hay, R ^a   Hamid, M A ^a   Hamdy, E ^b  

^a Dermatology Department   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Female pattern hair loss; Serum iron; Serum vitamin D; Telogen effluvium

Indexed keywords

ERGOCALCIFEROL; FERRITIN; VITAMIN D;

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPILUMINESCENCE MICROSCOPY; FEMALE; FEMALE PATTERN HAIR LOSS; FERRITIN BLOOD LEVEL; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TELOGEN EFFLUVIUM; TRICHOGRAM; VITAMIN BLOOD LEVEL; CASE CONTROL STUDY; DIAGNOSTIC PROCEDURE; PROSPECTIVE STUDY; SKIN EXAMINATION;

ADOLESCENT; ADULT; ALOPECIA; ERGOCALCIFEROLS; FEMALE; FERRITINS; HUMANS; MIDDLE AGED; YOUNG ADULT;

EID: 84874012504     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000346698     Document Type: Article

References (33)

1. Mounsey AL, Reed SW: Diagnosing and treating hair loss. Am Fam Physician 2009; 80: 356-362.
2. Shrivastava SB: Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol 2009; 75: 20-27.
3. Hard S: Non-anemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol 1963; 43: 562-569.
4. Bregy A, Trueb RM: No association between serum ferritin levels >10 microg/l and hair loss activity in women. Dermatology 2008; 217: 1-6.
5. Olsen EA, Reed KB, Cacchio PB, Caudill L: Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol 2010; 63: 991-999.
6. Moeinvaziri M, Mansoori P, Holakooee K, Safaee Naraghi Z, Abbasi A: Iron status in diffuse telogen hair loss among women. Acta Dermatovenerol Croat 2009; 17: 279-284.
7. Deloche C, Bastien P, Chadoutaud S, Galan P, Bertrais S, Hercberg S, de Lacharriere O: Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol 2007; 17: 507-512.
8. Trost LB, Bergfeld WF, Calogeras E: The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006; 54: 824-844.
9. Rushton DH, Ramsay ID: The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women. Clin Endocrinol (Oxf) 1992; 36: 421-427.
10. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G: Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121: 985-988.
11. Rushton DH: Decreased serum ferritin and alopecia in women. J Invest Dermatol 2003; 121:xvii-xviii.
12. Sinclair R: There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 2002; 147: 982-984.
13. Kennedy A, Kohn M, Lammi A, Clarke S: Iron status and haematological changes in adolescent female inpatients with anorexia nervosa. J Paediatr Child Health 2004; 40: 430-432.
14. Heldenberg D, Tenenbaum G, Weisman Y: Effect of iron on serum 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D concentrations. Am J Clin Nutr 1992; 56: 533-536.
15. Kiss Z, Ambrus C, Almasi C, Berta K, Deak G, Horonyi P, Kiss I, Lakatos P, Marton A, Molnar MZ, Nemeth Z, Szabo A, Mucsi I: Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 2010; 117:c373-c378.
16. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M: Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776.
17. Tsiaras WG, Weinstock MA: Factors influencing vitamin D status. Acta Derm Venereol 2011; 91: 115-124.
18. Wang J, Lu Z, Au JL: Protection against chemotherapy-induced alopecia. Pharm Res 2006; 23: 2505-2514.
19. De Lacharriere O, Deloche C, Misciali C, Piraccini BM, Vincenzi C, Bastien P, Tardy I, Bernard BA, Tosti A: Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. Arch Dermatol 2001; 137: 641-646.
20. Tosti A, Torres F: Dermoscopy in the diagnosis of hair and scalp disorders. Actas Dermosifiliogr 2009; 100: 114-119.
21. Tisma VS, Poljak-Blazi M: The role of oxidative stress and iron in pathophysiology of Rosacea. Lijec Vjesn 2011; 133: 288-291.
22. Baraka MA, Steurbaut S, Laubach M, Coomans D, Dupont AG: Iron status, iron supplementation and anemia in pregnancy: ethnic differences. J Matern Fetal Neonatal Med 2012; 25: 1305-1310.
23. De la Cruz-Gongora V, Gaona B, Villalpando S, Shamah-Levy T, Robledo R: Anemia and iron, zinc, copper and magnesium deficiency in Mexican adolescents: National Health and Nutrition Survey 2006. Salud Publica Mex 2012; 54: 135-145.
24. Cole CR, Grant FK, Swaby-Ellis ED, Smith JL, Jacques A, Northrop-Clewes CA, Caldwell KL, Pfeiffer CM, Ziegler TR: Zinc and iron deficiency and their interrelations in low-income African American and Hispanic children in Atlanta. Am J Clin Nutr 2010; 91: 1027-1034.
25. Amor KT, Rashid RM, Mirmirani P: Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J 2010; 16: 3.
26. Wu KJ, Polack A, Dalla-Favera R: Coordinated regulation of iron-controlling genes, Hferritin and Irp2, by c-Myc. Science 1999; 283: 676-679.
27. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR: Deregulated expression of c-Myc depletes epidermal stem cells. Nature Genet 2001; 28: 165-168.
28. Elledge SJ, Zhou Z, Allen JB: Ribonucleotide reductase: regulation, regulation, regulation. Trends Biochem Sci 1992; 17: 119-123.
29. Zheng Y, Prouty SM, Harmon A, Sundberg JP, Stenn KS, Parimoo S: Scd3-a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics 2001; 71: 182-191.
30. Bolland MJ, Ames RW, Grey AB, Horne AM, Mason BH, Gamble GD, Reid IR: Does degree of baldness influence vitamin D status? Med J Aust 2008; 189: 674-675.
31. Demay MB: The hair cycle and vitamin D receptor. Arch Biochem Biophys 2012; 523: 19-21.
32. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB: Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998; 139: 4391-4396.
33. Teichert A, Elalieh H, Bikle D: Disruption of the hedgehog signaling pathway contributes to the hair follicle cycling deficiency in VDR knockout mice. J Cell Physiol 2010; 225: 482-489.